Trial Profile
A multicenter randomized open trial to evaluate the efficacy of fentanyl pectin nasal spray (FPNS) versus Physician Choice (PC) - Usual Care (UC), in reducing incidental predictable breakthrough pain (IP-BTP) at swallowing in patients with head and neck cancer undergoing radiotherapy.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 13 Mar 2018
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Acronyms PE.R.F.E.C.T. F.A.S.T STUDY
- Sponsors Molteni Farmaceutici
- 13 Mar 2018 New trial record